Table of contents

Research Article

• Assessment of lupus: where are we now? (1 March, 1993)

  E Hay, C Gordon, P Emery
• Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis. (1 March, 1993)

  K Lehtinen
• Identification of tissue inhibitor of metalloproteinase-2 (TIMP-2)-progelatinase complex as the third metalloproteinase inhibitor peak in rheumatoid synovial fluid. (1 March, 1993)

  T E Cawston, H F Bigg, I M Clark, B L Hazleman
• Giant cells in arthritic synovium. (1 March, 1993)

  L S Wilkinson, A A Pitsillides, J C Edwards
• Protection from interleukin 1 induced destruction of articular cartilage by transforming growth factor beta: studies in anatomically intact cartilage in vitro and in vivo. (1 March, 1993)

  H M van Beuningen, P M van der Kraan, O J Arntz, W B van den Berg
• Altered Golgi apparatus in hydrostatically loaded articular cartilage chondrocytes. (1 March, 1993)

  J J Parkkinen, M J Lammi, A Pelttari, H J Helminen, M Tammi, I Virtanen
• Expression of public idiotypes in patients with Lyme arthritis. (1 March, 1993)

  J S Axford, R A Watts, A A Long, D A Isenberg, A C Steere
• Rational diagnosis and treatment in unclassified arthritis: how clinical data may guide requests for Lyme serology and antibiotic treatment. (1 March, 1993)

  I Blaauw, B Dijkmans, P Bouma, S van der Linden
• Depressed levels of dehydroepiandrosterone sulphate in postmenopausal women with rheumatoid arthritis but no relation with axial bone density. (1 March, 1993)

  G M Hall, L A Perry, T D Spector
• Modified suprascapular nerve block with bupivacaine alone effectively controls chronic shoulder pain in patients with rheumatoid arthritis. (1 March, 1993)

  K Gado, P Emery
• Cutaneous manifestations associated with antiphospholipid antibodies in patients with suspected primary antiphospholipid syndrome: a case-control study. (1 March, 1993)

  L Naldi, F Locati, L Marchesi, S Cortelazzo, G Finazzi, M Galli, A Brevi, T Cainelli, T Barbui
• Yersinia associated arthritis in SHR rats: effect of the microbial status of the host. (1 March, 1993)

  C Gripenberg-Lerche, P Toivanen
• Levels of insulin related growth factor 1 in osteoarthritis of the knee. (1 March, 1993)

  T E McAlindon, J D Teale, P A Dieppe
• Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity. (1 March, 1993)

  R Madhok, A Crilly, J Watson, H A Capell
• New application of myocardial antimyosin scintigraphy: diagnosis of myocardial disease in polymyositis. (1 March, 1993)

  D Le Guludec, F Lhote, P Weinmann, I Royer, B Jarrousse, N Caillat-Vigneron, L Guillevin, J L Moretti
• Rapidly progressive sacroiliitis in a patient with lymphocytic lymphoma. (1 March, 1993)

  M R Cohen, G E Carrera, J Lundberg
• Why are non-steroidal anti-inflammatory drugs so variable in their efficacy? A description of ion trapping. (1 March, 1993)

  G A Ellis, D R Blake
• RA sex ratios, HLA-DR, and testosterone. (1 March, 1993)

  C M Deighton, M Watson, D J Walker
• Dorsal vertebral fractures with 'normal' bone mineral density. (1 March, 1993)

  P Peris, N Guañabens, J Muñoz-Gómez
• von Willebrand factor, exercise, and ischemia/reperfusion injury. (1 March, 1993)

  A D Blann
• Elusive 'alpha-delta' sleep in fibromyalgia and osteoarthritis. (1 March, 1993)

  M Doherty, J Smith
• Rebound of anti-topoisomerase I antibody titres after plasma exchange. (1 March, 1993)

  F H Van den Hoogen, A M Boerbooms, L B Van de Putte, R Verheijen, W Van Venrooij, A J Croockewit
• Polyarteritis nodosa following angioplasty. (1 March, 1993)

  G R Struthers, M T Pugh, D A Woodward
• Buerger's disease and antiphospholipid antibodies in pregnancy. (1 March, 1993)

  M Casellas, A Pérez, L Cabero, A Segura, E Puig de Morales, R Selva O'Callaghan